Cheelcare Inc. CHCRF
OTC PK
| 07/31/2026 | 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 95.10% | 84.99% | 22.39% | -10.60% | 6.18% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 95.10% | 84.99% | 22.39% | -10.60% | 6.18% |
| Cost of Revenue | 66.33% | 156.29% | -0.84% | 0.43% | 40.28% |
| Gross Profit | 122.72% | -928.22% | 73.39% | -17.14% | -13.99% |
| SG&A Expenses | 173.60% | -13.60% | 85.74% | 155.13% | -2.73% |
| Depreciation & Amortization | 120.42% | 272.95% | 1,733.33% | 2,143.75% | 2,481.82% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 91.21% | 69.31% | 54.09% | 105.78% | 36.07% |
| Operating Income | -84.24% | -61.61% | -104.54% | -13,025.00% | -174.64% |
| Income Before Tax | 69.75% | -201.50% | -68.52% | -1,484.34% | -807.80% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 69.75% | -201.50% | -68.52% | -1,484.34% | -807.80% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 69.75% | -201.50% | -68.52% | -1,484.34% | -807.80% |
| EBIT | -84.24% | -61.61% | -104.54% | -13,025.00% | -174.64% |
| EBITDA | -114.34% | -70.32% | -98.91% | -7,509.09% | -132.89% |
| EPS Basic | 84.46% | -153.26% | 51.28% | -116.13% | -120.61% |
| Normalized Basic EPS | 84.47% | -116.48% | 51.18% | -117.24% | -120.92% |
| EPS Diluted | 84.46% | -153.26% | 51.28% | -116.13% | -120.61% |
| Normalized Diluted EPS | 84.47% | -116.48% | 51.18% | -117.24% | -120.92% |
| Average Basic Shares Outstanding | 94.11% | 18.99% | 245.19% | 635.56% | 311.31% |
| Average Diluted Shares Outstanding | 94.11% | 18.99% | 245.19% | 635.56% | 311.31% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |